Cargando…
Retracted: Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307320/ https://www.ncbi.nlm.nih.gov/pubmed/37387913 http://dx.doi.org/10.1155/2023/9853753 |
| _version_ | 1785066019586310144 |
|---|---|
| author | and Alternative Medicine, Evidence-Based Complementary |
| author_facet | and Alternative Medicine, Evidence-Based Complementary |
| author_sort | and Alternative Medicine, Evidence-Based Complementary |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10307320 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Hindawi |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103073202023-06-29 Retracted: Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas and Alternative Medicine, Evidence-Based Complementary Evid Based Complement Alternat Med Retraction Hindawi 2023-06-21 /pmc/articles/PMC10307320/ /pubmed/37387913 http://dx.doi.org/10.1155/2023/9853753 Text en Copyright © 2023 Evidence-Based Complementary and Alternative Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Retraction and Alternative Medicine, Evidence-Based Complementary Retracted: Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas |
| title | Retracted: Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas |
| title_full | Retracted: Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas |
| title_fullStr | Retracted: Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas |
| title_full_unstemmed | Retracted: Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas |
| title_short | Retracted: Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas |
| title_sort | retracted: low-dose apatinib improves the prognosis of patients with recurrent high-grade gliomas |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307320/ https://www.ncbi.nlm.nih.gov/pubmed/37387913 http://dx.doi.org/10.1155/2023/9853753 |
| work_keys_str_mv | AT andalternativemedicineevidencebasedcomplementary retractedlowdoseapatinibimprovestheprognosisofpatientswithrecurrenthighgradegliomas |